Title:
【発明の名称】腫瘍拒絶抗原先駆体をコード化する核酸分子
Document Type and Number:
Japanese Patent JP3433322
Kind Code:
B2
Abstract:
The invention relates to nucleic acid molecules coding for a tumor rejection antigen precursor. Specifically, the tumor rejection antigen precursor, or "TRAP", is processed into at least one tumor rejection antigen, which is presented by HLA-A2 molecules. Ramifications of the discovery are also set forth.
Inventors:
Vincent, brichard
Aleen van Pell
Traverse sari, katya
Wolfel, Thomas
Boone-Farrer, Thierry
Des Plains, Etienne
Aleen van Pell
Traverse sari, katya
Wolfel, Thomas
Boone-Farrer, Thierry
Des Plains, Etienne
Application Number:
JP52108894A
Publication Date:
August 04, 2003
Filing Date:
March 09, 1994
Export Citation:
Assignee:
Ludwig Institute for Cancer Research
International Classes:
C07H21/04; C07K14/47; C12N5/10; C12N15/09; C12P21/02; G01N33/574; A61K38/00; (IPC1-7): C12N15/09; C07K14/47; C12N5/10; C12P21/02; G01N33/574
Attorney, Agent or Firm:
Shuichiro Kitamura